Company Filing History:
1 out of 3,559 
1 out of 4,872 
1 out of 832,891 Years Active: 2003-2014
Title: Innovator Fabrice Beau: A Pioneer in Pharmaceutical Research
Introduction
Fabrice Beau, an innovative inventor based in Massy, France, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Beau is recognized for his groundbreaking work in developing compounds that act as inhibitors for metalloproteinases, which play a crucial role in various biological processes.
Latest Patents
One of Fabrice Beau's latest patents is focused on pseudodipeptides as MMP inhibitors. This invention relates to a series of compounds that inhibit metalloproteinases, making them particularly valuable in the pharmaceutical field. The patent highlights the importance of these compounds in treating diseases characterized by abnormal metalloproteinase activity. Additionally, Beau has developed labeled compounds that serve as contrast agents for detecting extracellular matrix metalloproteinases, showcasing his innovative approach to pharmaceutical research.
Another noteworthy patent involves a method for screening groups of radioactive molecules, which offers an amplification-free technique for examining the distribution of radioactivity in animal tissues. This method includes several systematic steps, from administering the radioactive molecules to analyzing the resultant tissue samples using advanced techniques such as chromatography and mass spectrometry.
Career Highlights
Fabrice Beau has worked with esteemed organizations, including the Commissariat à l'Énergie Atomique, where his research focused on advancing pharmaceutical applications of his inventions. His work has significantly contributed to the understanding of enzyme mechanisms and the development of therapeutic agents.
Collaborations
Throughout his career, Beau has collaborated with prominent researchers, including Vincent Dive and Bertrand Czarny. These collaborations highlight the interdisciplinary nature of his work and the importance of collaborative efforts in driving innovation within the pharmaceutical industry.
Conclusion
Fabrice Beau's innovative spirit and dedication to pharmaceutical research have established him as a notable inventor. With his recent patents focused on MMP inhibitors and radioactive molecule screening methods, he continues to push the boundaries of science and technology, paving the way for novel therapeutic options in medicine. His contributions are a testament to the impact of his work on healthcare and the ongoing need for innovation in the pharmaceutical sector.